Research graph
References from Hantaviruses at an inflection point: scientific evidence, spillover risk, and One Health approach. Local targets link to admitted publications; unresolved targets remain external evidence.
Hantaviruses
10.1016/j.cll.2010.01.004 · 2010 · External reference
Hantaviruses: a short review
10.5858/2003-127-30-hasr · 2003 · External reference
A brief history of bunyaviral family Hantaviridae
10.3390/diseases11010038 · 2023 · External reference
HFRS after a wild rodent bite in the Haute-Savoie—and risk of exposure to Hantaan-like virus in a Paris laboratory
1984 · External reference
Our Hantaan virus became a new family, Hantaviridae in the classification of order Bunyavirales. It will remain as a history of virology
10.4167/jbv.2019.49.2.45 · 2019 · External reference
Unresolved reference
2026 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Epidemiology of hantavirus infections in humans: a comprehensive global overview
10.3109/1040841x.2013.783555 · 2014 · External reference
A global perspective on hantavirus ecology, epidemiology, and disease
10.1128/cmr.00062-09 · 2010 · External reference
Hemorrhagic fever with renal syndrome in Asia: history, pathogenesis, diagnosis, treatment, and prevention
10.3390/v15020561 · 2023 · External reference
Unresolved reference
2026 · External reference
Factors driving hantavirus emergence in Europe
10.1016/j.coviro.2013.01.002 · 2013 · External reference
Hantavirus infections in Europe and their impact on public health
10.1002/rmv.1722 · 2013 · External reference
Hantavirus research in Finland: highlights and perspectives
10.3390/v13081452 · 2021 · External reference
Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor
10.1017/s0950268817002904 · 2018 · External reference
Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate
10.1017/s0950268808000940 · 2009 · External reference
Detection of Dobrava hantavirus RNA in Apodemus mice in Bulgaria
10.1002/jmv.24033 · 2015 · External reference
Viral zoonoses in humans (zooanthroponoses) with similar clinical manifestation
2017 · External reference
Clinical aspects of hantavirus infections in Bulgaria
10.1007/s00508-017-1174-2 · 2017 · External reference
Hantaviruses in small mammals in two regions in Bulgaria
2021 · External reference
Hantaviruses in the americas and their role as emerging pathogens
10.3390/v2122559 · 2010 · External reference
10.2139/ssrn.6620250
10.2139/ssrn.6620250 · 2026 · External reference
Hantavirus infection: a review and global update
10.3855/jidc.317 · 2008 · External reference
The ecological dynamics of hantavirus diseases
10.1371/journal.pntd.0006901 · 2019 · External reference
Hantaviruses and climate change
10.1111/j.1469-0691.2009.02848.x · 2009 · External reference
Outbreaks of hantavirus induced by seasonality
10.1103/physreve.69.021906 · 2004 · External reference
Hantavirus (Hantavirus spp.)
10.1002/9781119985853.ch7.1 · 2025 · External reference
Zoonotic Hantaviridae with global public health significance
10.3390/v15081705 · 2023 · External reference
Hantaviridae: current classification and future perspectives
10.3390/v11090788 · 2019 · External reference
ICTV virus taxonomy profile: hantaviridae 2024
10.1099/jgv.0.001975 · 2024 · External reference
Dobrava-Belgrade virus: phylogeny, epidemiology, disease
10.1016/j.antiviral.2012.05.011 · 2012 · External reference
Hantavirus infections by Puumala or Dobrava-Belgrade virus in pregnant women
10.1016/j.jcv.2012.07.011 · 2012 · External reference
Cyclic hantavirus epidemics in humans predicted by rodent host dynamics
10.1016/j.epidem.2009.03.002 · 2009 · External reference
Hantavirus replication cycle—an updated structural virology perspective
10.3390/v13081561 · 2021 · External reference
Hantavirus structure—molecular interactions behind the scene
10.1099/vir.0.042218-0 · 2012 · External reference
High-resolution in situ structures of hantavirus glycoprotein tetramers
10.1016/j.cell.2026.01.030 · 2026 · External reference
Hantavirus: an overview and advancements in therapeutic approaches for infection
10.3389/fmicb.2023.1233433 · 2023 · External reference
Epidemiology, virology and clinical aspects of hantavirus infections: an overview
10.1080/09603123.2021.1917527 · 2022 · External reference
Ecology of hantavirus in a changing world
2010 · External reference
Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence
10.1093/molbev/msn234 · 2009 · External reference
What do we know about how hantaviruses interact with their different hosts
10.3390/v8080223 · 2016 · External reference
Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment
10.1099/vir.0.81643-0 · 2006 · External reference
Person-to-person transmission of Andes virus
10.3201/eid1112.050501 · 2005 · External reference
Super-spreaders” and person-to-person transmission of Andes virus in Argentina
10.3201/eid1112.050501 · 2020 · External reference
Mother-to-child transmission of Andes virus through breast milk, Chile
10.3201/eid2608.200204 · 2020 · External reference
Presence and persistence of Andes virus RNA in human semen
10.3390/v15112266 · 2023 · External reference
Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome
10.3201/eid1403.071242 · 2008 · External reference
Evidence for human-to-human transmission of hantavirus: a systematic review
10.1093/infdis/jiab461 · 2022 · External reference
Hantavirus infections
2015 · External reference
Unresolved reference
External reference
Increased risk of acute myocardial infarction and stroke during hemorrhagic fever with renal syndrome: a self-controlled case series study
10.1161/circulationaha.113.001870 · 2014 · External reference
Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients
10.1136/bjo.2010.185413 · 2011 · External reference
Regulatory T cell response correlates with the severity of human hantavirus infection
10.1016/j.jinf.2013.11.007 · 2014 · External reference
Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome
10.1111/1469-0691.12218 · 2013 · External reference
Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells
10.7554/elife.69708 · 2021 · External reference
Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus
10.1080/23744235.2017.1293841 · 2017 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America
10.1086/425007 · 2004 · External reference
Hantavirus pulmonary syndrome
2024 · External reference
Evidence of disseminated intravascular coagulation in hemorrhagic fever with renal syndrome—scoring models and severe illness
10.1371/journal.pone.0021134 · 2011 · External reference
High infection rate of bank voles (Myodes glareolus) with Puumala virus is associated with a winter outbreak of haemorrhagic fever with renal syndrome in Croatia
10.1017/s095026881300321x · 2014 · External reference
Clinical and laboratory findings in patients with oliguric and non-oliguric hantavirus haemorrhagic fever with renal syndrome: an analysis of 128 patients
10.1111/j.1469-0691.2012.03994.x · 2013 · External reference
Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome
10.1371/journal.pone.0197661 · 2018 · External reference
Hemorrhagic fever renal syndrome
2023 · External reference
Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis
10.1016/s0928-0197(97)10019-8 · 1998 · External reference
External quality assessment of orthohantavirus and lymphocytic choriomeningitis virus molecular detection and serology in Europ
10.2807/1560-7917.es.2023.28.40.2300054 · 2023 · External reference
Seroprevalence of hantavirus infection in non-endemic settings over four decades: a systematic review and meta-analysis
10.1186/s12889-024-20014-w · 2024 · External reference
Hanta hemorrhagic fever with renal syndrome: a pathology in whose diagnosis kidney biopsy plays a major role
10.3892/etm.2021.10416 · 2021 · External reference
A framework for understanding and predicting orthohantavirus functional traits
10.1016/j.tim.2023.05.004 · 2023 · External reference
Development of RT-qPCR and semi-nested RT-PCR assays for molecular diagnosis of hantavirus pulmonary syndrome
10.1371/journal.pntd.0007884 · 2019 · External reference
Diagnosis of hantavirus infection in humans
10.1586/14787210.2015.1047825 · 2015 · External reference
Laboratory diagnosis of human hantavirus infection: novel insights and future potential
10.2217/fvl.09.15 · 2009 · External reference
Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test
10.1016/s0166-0934(02)00282-3 · 2003 · External reference
How to diagnose hantavirus infections and detect them in rodents and insectivores
10.1002/rmv.581 · 2008 · External reference
Vaccines and therapeutics against hantaviruses
10.3389/fmicb.2019.02989 · 2019 · External reference
Effectiveness of ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis
10.1007/s13337-014-0219-7 · 2014 · External reference
Long-term consequences of Puumala hantavirus infection
10.3390/v14030598 · 2022 · External reference
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
10.1038/s41467-023-40126-y · 2023 · External reference
Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant
10.3109/00365548.2012.755268 · 2014 · External reference
Hantavirus in humans: a review of clinical aspects and management
10.1016/s1473-3099(23)00128-7 · 2023 · External reference
Enhanced nanobiotechnological strategy against SARS-coV-2: synergistic potential of rutin
10.2174/0126667975464024260213054706 · 2026 · External reference
Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–β-escin conjugates as SARS-CoV-2 inhibitors
10.1515/biol-2022-1047 · 2025 · External reference
Green-synthesized colloidal metal–β-escin bioconjugates for nasal delivery: A hypothetical prophylactic and therapeutic product against SARS-coV-2 variants
10.48048/tis.2025.9826 · 2025 · External reference
A computational study on gold and silver nanoparticles against SARS-coV-2 proteins
10.3390/proceedings2024103023 · 2024 · External reference
Recent approaches in hantavirus vaccine development
10.1586/14760584.8.1.67 · 2009 · External reference
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)
10.1016/j.vaccine.2013.07.025 · 2013 · External reference
Immune response during hantavirus diseases: implications for immunotherapies and vaccine design
10.1111/imm.13322 · 2021 · External reference
Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome
10.1093/infdis/jiy037 · 2018 · External reference
Protective effectiveness of hantavirus vaccine
10.3201/eid1012.040684 · 2004 · External reference
Vaccines for hantaviruses
10.1016/j.vaccine.2009.07.096 · 2009 · External reference
Progress on the prevention and treatment of hantavirus disease
10.3390/v11070610 · 2019 · External reference
Hantavirus infections—treatment and prevention
10.1007/s40506-020-00236-3 · 2020 · External reference
Hantavirus infections and their prevention
10.1016/s1286-4579(01)01474-5 · 2001 · External reference
New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention-a review
10.1007/s11262-004-5625-2 · 2005 · External reference
What is the time-scale of hantavirus evolution
10.1016/j.meegid.2014.04.017 · 2014 · External reference
The evolution and emergence of hantaviruses
10.1016/j.coviro.2014.12.007 · 2015 · External reference
Hantaviruses: Molecular biology, evolution and pathogenesis
10.2174/156652405774962317 · 2005 · External reference
Evolution of hantaviruses: co-speciation with reservoir hosts for more than 100 MYR
10.1016/j.virusres.2014.01.008 · 2014 · External reference
Molecular evolution of Puumala hantavirus
10.1128/jvi.75.23.11803-11810.2001 · 2001 · External reference
Re-emergence of monkeypox: a post-COVID-19 challenge
10.31300/ctimm.24.2023.21-29 · 2023 · External reference
Unveiling monkeypox virus emergence: What unfolded in the aftermath of the COVID-19 threat
10.31300/ctimm.24.2023.9-20 · 2023 · External reference
Assessing the knowledge of smallpox and monkeypox virus among the University of Tlemcen members in the wake of COVID-19: A 2023 cross-sectional study
10.21010/ajidv18i1.2 · 2024 · External reference
Tracing the origin and early progression of COVID-19 in Europe: An epidemiological descriptive study
10.61186/iem.9.3.249 · 2023 · External reference
COVID-19 in North Africa: An epidemiological analysis of cases, deaths, and vaccination efforts, (2020-2023)
10.61186/iem.9.4.349 · 2023 · External reference
Profiling COVID-19 cases in Tlemcen, Algeria: PCR and CT imaging insights
10.3390/covid5090149 · 2025 · External reference
Assessment of COVID-19 vaccination performance in Tlemcen: Insights into vaccine inventory management
10.21608/mid.2025.307979.2112 · 2025 · External reference
Hantavirus: the next pandemic we are waiting for
10.1007/s12539-020-00413-4 · 2021 · External reference
Hantavirus: Third British national has suspected infection as WHO says this is “not the start of a pandemic
10.1136/bmj.s899 · 2026 · External reference
Navigating the molecular diversity of SARS-CoV-2: Early pandemic insights from comparative phylogenetic analysis
10.5584/jiomics.v14i1.228 · 2024 · External reference
Exploring the Interplay of UV Index, Population Density, and SARS-CoV-2 Clades on COVID-19 Propagation: A Comprehensive Analysis of the Pandemic Dynamics
10.61186/iem.10.1.61 · 2024 · External reference
Hantaviruses
2026 · External reference
Hantaviruses: Bridging species, crossing borders
10.1201/9781003607816-5 · 2026 · External reference
Hantavirus (Hantavirus spp.)
10.1002/9781119985853.ch7.1 · ExternalCitation · doi-reference
Detection of Dobrava hantavirus RNA in Apodemus mice in Bulgaria
10.1002/jmv.24033 · ExternalCitation · doi-reference
Hantavirus infections in Europe and their impact on public health
10.1002/rmv.1722 · ExternalCitation · doi-reference
How to diagnose hantavirus infections and detect them in rodents and insectivores
10.1002/rmv.581 · ExternalCitation · doi-reference
Clinical aspects of hantavirus infections in Bulgaria
10.1007/s00508-017-1174-2 · ExternalCitation · doi-reference
New ecological aspects of hantavirus infection: a change of a paradigm and a challenge of prevention-a review
10.1007/s11262-004-5625-2 · ExternalCitation · doi-reference
Hantavirus: the next pandemic we are waiting for
10.1007/s12539-020-00413-4 · ExternalCitation · doi-reference
Effectiveness of ribavirin in treatment of hantavirus infections in the Americas and Eurasia: a meta-analysis
10.1007/s13337-014-0219-7 · ExternalCitation · doi-reference
Hantavirus infections—treatment and prevention
10.1007/s40506-020-00236-3 · ExternalCitation · doi-reference
Dobrava-Belgrade virus: phylogeny, epidemiology, disease
10.1016/j.antiviral.2012.05.011 · ExternalCitation · doi-reference
High-resolution in situ structures of hantavirus glycoprotein tetramers
10.1016/j.cell.2026.01.030 · ExternalCitation · doi-reference
Hantaviruses
10.1016/j.cll.2010.01.004 · ExternalCitation · doi-reference
Factors driving hantavirus emergence in Europe
10.1016/j.coviro.2013.01.002 · ExternalCitation · doi-reference
The evolution and emergence of hantaviruses
10.1016/j.coviro.2014.12.007 · ExternalCitation · doi-reference
Cyclic hantavirus epidemics in humans predicted by rodent host dynamics
10.1016/j.epidem.2009.03.002 · ExternalCitation · doi-reference
Hantavirus infections by Puumala or Dobrava-Belgrade virus in pregnant women
10.1016/j.jcv.2012.07.011 · ExternalCitation · doi-reference
Regulatory T cell response correlates with the severity of human hantavirus infection
10.1016/j.jinf.2013.11.007 · ExternalCitation · doi-reference
What is the time-scale of hantavirus evolution
10.1016/j.meegid.2014.04.017 · ExternalCitation · doi-reference
A framework for understanding and predicting orthohantavirus functional traits
10.1016/j.tim.2023.05.004 · ExternalCitation · doi-reference
Vaccines for hantaviruses
10.1016/j.vaccine.2009.07.096 · ExternalCitation · doi-reference
A novel Sin Nombre virus DNA vaccine and its inclusion in a candidate pan-hantavirus vaccine against hantavirus pulmonary syndrome (HPS) and hemorrhagic fever with renal syndrome (HFRS)
10.1016/j.vaccine.2013.07.025 · ExternalCitation · doi-reference
Evolution of hantaviruses: co-speciation with reservoir hosts for more than 100 MYR
10.1016/j.virusres.2014.01.008 · ExternalCitation · doi-reference
Diagnostic rapid tests for acute hantavirus infections: specific tests for Hantaan, Dobrava and Puumala viruses versus a hantavirus combination test
10.1016/s0166-0934(02)00282-3 · ExternalCitation · doi-reference
Evaluation of Puumala virus IgG and IgM enzyme immunoassays based on recombinant baculovirus-expressed nucleocapsid protein for early nephropathia epidemica diagnosis
10.1016/s0928-0197(97)10019-8 · ExternalCitation · doi-reference
Hantavirus infections and their prevention
10.1016/s1286-4579(01)01474-5 · ExternalCitation · doi-reference
Hantavirus in humans: a review of clinical aspects and management
10.1016/s1473-3099(23)00128-7 · ExternalCitation · doi-reference
Hantavirus disease (nephropathia epidemica) in Belgium: effects of tree seed production and climate
10.1017/s0950268808000940 · ExternalCitation · doi-reference
High infection rate of bank voles (Myodes glareolus) with Puumala virus is associated with a winter outbreak of haemorrhagic fever with renal syndrome in Croatia
10.1017/s095026881300321x · ExternalCitation · doi-reference
Population-based seroprevalence of Puumala hantavirus in Finland: smoking as a risk factor
10.1017/s0950268817002904 · ExternalCitation · doi-reference
Two point mutations in protocadherin-1 disrupt hantavirus recognition and afford protection against lethal infection
10.1038/s41467-023-40126-y · ExternalCitation · doi-reference
Epidemiology, virology and clinical aspects of hantavirus infections: an overview
10.1080/09603123.2021.1917527 · ExternalCitation · doi-reference
Insufficient efficacy and safety of intravenous ribavirin in treatment of haemorrhagic fever with renal syndrome caused by Puumala virus
10.1080/23744235.2017.1293841 · ExternalCitation · doi-reference
Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America
10.1086/425007 · ExternalCitation · doi-reference
Evidence for human-to-human transmission of hantavirus: a systematic review
10.1093/infdis/jiab461 · ExternalCitation · doi-reference
Protective effectiveness of inactivated hantavirus vaccine against hemorrhagic fever with renal syndrome
10.1093/infdis/jiy037 · ExternalCitation · doi-reference
Hantavirus evolution in relation to its rodent and insectivore hosts: no evidence for codivergence
10.1093/molbev/msn234 · ExternalCitation · doi-reference
ICTV virus taxonomy profile: hantaviridae 2024
10.1099/jgv.0.001975 · ExternalCitation · doi-reference
Hantavirus structure—molecular interactions behind the scene
10.1099/vir.0.042218-0 · ExternalCitation · doi-reference
Prolonged survival of Puumala hantavirus outside the host: evidence for indirect transmission via the environment
10.1099/vir.0.81643-0 · ExternalCitation · doi-reference
Outbreaks of hantavirus induced by seasonality
10.1103/physreve.69.021906 · ExternalCitation · doi-reference
Viral load and immune response dynamics in patients with haemorrhagic fever with renal syndrome
10.1111/1469-0691.12218 · ExternalCitation · doi-reference
Immune response during hantavirus diseases: implications for immunotherapies and vaccine design
10.1111/imm.13322 · ExternalCitation · doi-reference
Hantaviruses and climate change
10.1111/j.1469-0691.2009.02848.x · ExternalCitation · doi-reference
Clinical and laboratory findings in patients with oliguric and non-oliguric hantavirus haemorrhagic fever with renal syndrome: an analysis of 128 patients
10.1111/j.1469-0691.2012.03994.x · ExternalCitation · doi-reference
A global perspective on hantavirus ecology, epidemiology, and disease
10.1128/cmr.00062-09 · ExternalCitation · doi-reference
Molecular evolution of Puumala hantavirus
10.1128/jvi.75.23.11803-11810.2001 · ExternalCitation · doi-reference
Prospective study on ocular findings in acute Puumala hantavirus infection in hospitalised patients
10.1136/bjo.2010.185413 · ExternalCitation · doi-reference
Hantavirus: Third British national has suspected infection as WHO says this is “not the start of a pandemic
10.1136/bmj.s899 · ExternalCitation · doi-reference
Increased risk of acute myocardial infarction and stroke during hemorrhagic fever with renal syndrome: a self-controlled case series study
10.1161/circulationaha.113.001870 · ExternalCitation · doi-reference
Seroprevalence of hantavirus infection in non-endemic settings over four decades: a systematic review and meta-analysis
10.1186/s12889-024-20014-w · ExternalCitation · doi-reference
Hantaviruses: Bridging species, crossing borders
10.1201/9781003607816-5 · ExternalCitation · doi-reference
The ecological dynamics of hantavirus diseases
10.1371/journal.pntd.0006901 · ExternalCitation · doi-reference
Development of RT-qPCR and semi-nested RT-PCR assays for molecular diagnosis of hantavirus pulmonary syndrome
10.1371/journal.pntd.0007884 · ExternalCitation · doi-reference
Evidence of disseminated intravascular coagulation in hemorrhagic fever with renal syndrome—scoring models and severe illness
10.1371/journal.pone.0021134 · ExternalCitation · doi-reference
Sequential assessment of clinical and laboratory parameters in patients with hemorrhagic fever with renal syndrome
10.1371/journal.pone.0197661 · ExternalCitation · doi-reference
Battling COVID-19 leveraging nanobiotechnology: Gold and silver nanoparticle–β-escin conjugates as SARS-CoV-2 inhibitors
10.1515/biol-2022-1047 · ExternalCitation · doi-reference
Recent approaches in hantavirus vaccine development
10.1586/14760584.8.1.67 · ExternalCitation · doi-reference
Diagnosis of hantavirus infection in humans
10.1586/14787210.2015.1047825 · ExternalCitation · doi-reference
Assessing the knowledge of smallpox and monkeypox virus among the University of Tlemcen members in the wake of COVID-19: A 2023 cross-sectional study
10.21010/ajidv18i1.2 · ExternalCitation · doi-reference
10.2139/ssrn.6620250
10.2139/ssrn.6620250 · ExternalCitation · doi-reference
Assessment of COVID-19 vaccination performance in Tlemcen: Insights into vaccine inventory management
10.21608/mid.2025.307979.2112 · ExternalCitation · doi-reference
Enhanced nanobiotechnological strategy against SARS-coV-2: synergistic potential of rutin
10.2174/0126667975464024260213054706 · ExternalCitation · doi-reference
Hantaviruses: Molecular biology, evolution and pathogenesis
10.2174/156652405774962317 · ExternalCitation · doi-reference
Laboratory diagnosis of human hantavirus infection: novel insights and future potential
10.2217/fvl.09.15 · ExternalCitation · doi-reference
External quality assessment of orthohantavirus and lymphocytic choriomeningitis virus molecular detection and serology in Europ
10.2807/1560-7917.es.2023.28.40.2300054 · ExternalCitation · doi-reference
Pathophysiology of a severe case of Puumala hantavirus infection successfully treated with bradykinin receptor antagonist icatibant
10.3109/00365548.2012.755268 · ExternalCitation · doi-reference
Epidemiology of hantavirus infections in humans: a comprehensive global overview
10.3109/1040841x.2013.783555 · ExternalCitation · doi-reference
Re-emergence of monkeypox: a post-COVID-19 challenge
10.31300/ctimm.24.2023.21-29 · ExternalCitation · doi-reference
Unveiling monkeypox virus emergence: What unfolded in the aftermath of the COVID-19 threat
10.31300/ctimm.24.2023.9-20 · ExternalCitation · doi-reference
Protective effectiveness of hantavirus vaccine
10.3201/eid1012.040684 · ExternalCitation · doi-reference
Super-spreaders” and person-to-person transmission of Andes virus in Argentina
10.3201/eid1112.050501 · ExternalCitation · doi-reference
Hantavirus RNA in saliva from patients with hemorrhagic fever with renal syndrome
10.3201/eid1403.071242 · ExternalCitation · doi-reference
Mother-to-child transmission of Andes virus through breast milk, Chile
10.3201/eid2608.200204 · ExternalCitation · doi-reference
Vaccines and therapeutics against hantaviruses
10.3389/fmicb.2019.02989 · ExternalCitation · doi-reference
Hantavirus: an overview and advancements in therapeutic approaches for infection
10.3389/fmicb.2023.1233433 · ExternalCitation · doi-reference
Profiling COVID-19 cases in Tlemcen, Algeria: PCR and CT imaging insights
10.3390/covid5090149 · ExternalCitation · doi-reference
A brief history of bunyaviral family Hantaviridae
10.3390/diseases11010038 · ExternalCitation · doi-reference
A computational study on gold and silver nanoparticles against SARS-coV-2 proteins
10.3390/proceedings2024103023 · ExternalCitation · doi-reference
Progress on the prevention and treatment of hantavirus disease
10.3390/v11070610 · ExternalCitation · doi-reference
Hantaviridae: current classification and future perspectives
10.3390/v11090788 · ExternalCitation · doi-reference
Hantavirus research in Finland: highlights and perspectives
10.3390/v13081452 · ExternalCitation · doi-reference
Hantavirus replication cycle—an updated structural virology perspective
10.3390/v13081561 · ExternalCitation · doi-reference
Long-term consequences of Puumala hantavirus infection
10.3390/v14030598 · ExternalCitation · doi-reference
Hemorrhagic fever with renal syndrome in Asia: history, pathogenesis, diagnosis, treatment, and prevention
10.3390/v15020561 · ExternalCitation · doi-reference
Zoonotic Hantaviridae with global public health significance
10.3390/v15081705 · ExternalCitation · doi-reference
Presence and persistence of Andes virus RNA in human semen
10.3390/v15112266 · ExternalCitation · doi-reference
Hantaviruses in the americas and their role as emerging pathogens
10.3390/v2122559 · ExternalCitation · doi-reference
What do we know about how hantaviruses interact with their different hosts
10.3390/v8080223 · ExternalCitation · doi-reference
Hantavirus infection: a review and global update
10.3855/jidc.317 · ExternalCitation · doi-reference
Hanta hemorrhagic fever with renal syndrome: a pathology in whose diagnosis kidney biopsy plays a major role
10.3892/etm.2021.10416 · ExternalCitation · doi-reference
Our Hantaan virus became a new family, Hantaviridae in the classification of order Bunyavirales. It will remain as a history of virology
10.4167/jbv.2019.49.2.45 · ExternalCitation · doi-reference
Green-synthesized colloidal metal–β-escin bioconjugates for nasal delivery: A hypothetical prophylactic and therapeutic product against SARS-coV-2 variants
10.48048/tis.2025.9826 · ExternalCitation · doi-reference
Navigating the molecular diversity of SARS-CoV-2: Early pandemic insights from comparative phylogenetic analysis
10.5584/jiomics.v14i1.228 · ExternalCitation · doi-reference
Hantaviruses: a short review
10.5858/2003-127-30-hasr · ExternalCitation · doi-reference
Exploring the Interplay of UV Index, Population Density, and SARS-CoV-2 Clades on COVID-19 Propagation: A Comprehensive Analysis of the Pandemic Dynamics
10.61186/iem.10.1.61 · ExternalCitation · doi-reference
Tracing the origin and early progression of COVID-19 in Europe: An epidemiological descriptive study
10.61186/iem.9.3.249 · ExternalCitation · doi-reference
COVID-19 in North Africa: An epidemiological analysis of cases, deaths, and vaccination efforts, (2020-2023)
10.61186/iem.9.4.349 · ExternalCitation · doi-reference
Genetic depletion studies inform receptor usage by virulent hantaviruses in human endothelial cells
10.7554/elife.69708 · ExternalCitation · doi-reference
